NCT03391830View on ClinicalTrials.gov

Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy

NACompletedINTERVENTIONAL
Enrollment

250

Participants

Timeline

Start Date

January 15, 2018

Primary Completion Date

January 1, 2020

Study Completion Date

January 1, 2020

Conditions
Contrast-induced NephropathyStatinAscorbic AcidAKI
Interventions
DRUG

Atorvastatin-Ascorbic acid

atorvastatin (80-mg loading dose given a mean 24 hours before procedure with another 40-mg dose approximately 2 hours before the procedure and for 3 days) plus ascorbic acid 500mg

DRUG

Placebo

Placebo

Trial Locations (1)

35516

Urology and Nephrology Center, Al Mansurah

All Listed Sponsors
lead

Mansoura University

OTHER

NCT03391830 - Effects Of Combination Therapy Of Statin And Ascorbic Acid For Prevention Of Contrast-Induced Nephropathy | Biotech Hunter | Biotech Hunter